Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 200
- 主要终点
- Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis
研究概览
简要总结
Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis
详细描述
Diagnosed EKC patients will be devided into two groups,first group will undergo povidone-iodine 2% eye drop four times a day and the control group will be treated only by artificial tear drops,they will be examined 3 months later and evaluations and data collections for the final comparison will be done.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 17 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients suspected for viral conjunctivitis
排除标准
- •Allergic to iodized materials
- •Age under 17
研究组 & 干预措施
EKC patients
Povidone-iodine 2% eye drop will be prescribed four times a day All patients will learn how to improve the hygiene level in order to reduce transmission
干预措施: Povidone Ophthalmic (Drug)
结局指标
主要结局
Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis
时间窗: 3 months
Decreased patient's symptoms
Povidone-iodine 2% eye drop
时间窗: 3 months
Decreased viral load based on PCR results
次要结局
未报告次要终点
研究者
mohammad soleimani
Associate professor of ophthalmology
Farabi Eye Hospital